High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial

Author: Laurell Anna   Kolstad Arne   Jerkeman Mats   Räty Riikka   Geisler Christian H.  

Publisher: Informa Healthcare

ISSN: 1042-8194

Source: Leukemia and Lymphoma, Vol.55, Iss.5, 2014-05, pp. : 1206-1208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content